Background and Purpose: Cerebral intraventricular infusion of acidic or basic fibroblast growth factor has been shown to attenuate ischemic damage to hippocampal CA1 neurons in the gerbil. The purpose of the present study was to determine if the basic fibroblast growth factor transgenic mouse has an enhanced
A ddition of fibroblast growth factor (FGF) to cultures of dissociated hippocampal neurons reduces glutamate-induced increases of intracellular calcium and as a result increases the threshold for glutamate neurotoxicity.1 Because increases of extracellular glutamate and intracellular calcium are believed to be major factors in the pathogenesis of hypoxic-ischemic brain damage,2-4 this observation suggests that FGF should have a protective effect on hypoxic-ischemic brain. This proposal is supported by observations that intraventricular infusions of acidic FGF5,6 and basic FGF7 (bFGF) protect hippocampal CA1 neurons in the ischemic gerbil brain. In addition, Yamada et al8 have shown that repeated intracisternal injections of bFGF prevent thalamic degeneration after cortical infarction in the rat.
The availability of an animal species that has enhanced cerebral expression of basic FGF has provided an opportunity to directly test the hypothesis that FGFs have a protective action in cerebral ischemia. The model is a See Editorial Comment, page 1739 transgenic (TG) mouse incorporating a transgene consisting of a Rous sarcoma virus enhancer fused to bovine bFGF cDNA. 9 This mouse has been demonstrated to express the transgene mRNA in brain, heart, and skeletal muscle, and increased immunoreactive bFGF is present by Western analysis (see "Results").
The objective of the present study was to determine if the bFGF expressing TG mouse has an enhanced ability to resist the effects of severe cerebral hypoxemia-oligemia.
Materials and Methods Transgenic Mice
The plasmid used for pronuclear injection was made using the pBC12/RSV/CAT plasmid10 containing the RSV-LTR promoter/enhancer, rat pre-proinsulin intronic sequences, and the SV40 polyadenylation signal. The HindIII-BamHI fragment containing the CAT gene was removed, and a 1. mol/L NaCl, 10 mmol/L Tris, pH 7.4, 0.1% CHAPS, followed by 10 column volumes 0.9 mol/L NaCl, 10 mmol/L Tris (pH 7.4), and 0.1% CHAPS. Heparinbinding proteins were eluted from the column with 1.5 mL of 2 mol/L NaCl, 10 mmol/L Tris (pH 7.4), and 0.1% CHAPS. Eluates were concentrated in Centricon 10 microconcentrator tubes (Amicon Corp, Danvers, Mass), electrophoresed on 12% polyacrylamide/sodium dodecyl sulfate gels, and transferred to a nylon membrane. Western analysis was performed using a monoclonal antibody to human bFGF (a gift from Dr Thomas Reilly, Du Pont-Merck, Inc). Immunoreactive bands were detected using secondary antibodies conjugated to horseradish peroxidase and developed with diaminobenzidine.
Hypoxemic-Ischemic Exposure
The experiments were carried out on mice of both sexes that were TG for bovine bFGF. NTG littermates of both sexes were used as controls. Animals were allowed free access to water and commercial mouse pellets. Before hypoxemic-ischemic exposure the mice were anesthetized with 2.5% halothane in 30% 02/70% N20, and the right carotid artery was surgically exposed and double ligated with 5-0 silk. Two hours later the animals were intraperitoneally injected with 0.25 mL 25% dextrose in H20 and 0.5 hours later were placed in a plastic bell jar (0.01 m3), which was flushed with 1% carbon monoxide in air at a rate of 5 L/min. After 20 minutes of exposure the animals were returned to room air. At 5 days of recovery the animals were anesthetized with pentobarbital (150 mg/kg IP), and the brain was fixed in situ by intracardiac perfusion of 100 to 125 mL of 10% formaldehyde, which was preceded by a brief 10 to 15 mL 0.9% saline washout. The fixed brain was subsequently prepared for paraffin sections (6 gim), stained with cresyl violet, and assessed for histological damage by counting of intact CA1 neurons and measurement of area of cerebral infarction using a video image processing program. Sections for analysis were taken at -1.0, -1.5, and -2.0 mm to the bregma. The experimenter performing the tissue analysis was blinded as to genotype until the completion of the study.
The results were analyzed using Wilcoxon's ranked sum test for unpaired samples, with P< .05 considered statistically significant.
Results

Transgene Expression
The results of RNase protection analysis of tissues from a TG mouse are shown in Fig 1 Table) .
Nineteen NTG and 17 TG mice were exposed to the sequence of right carotid occlusion, glucose injection, and 1% carbon monoxide. Four of the NTG and 5 of the TG mice experienced acute cardiovascular collapse, pulmonary edema, respiratory failure, and death either at the terminal stages of the carbon monoxide exposure or during the first few hours of reoxygenation. These deaths were judged to be due to the well-documented cardiac toxicity of acute carbon monoxide poisoning.13 In surviving animals, areas of right cerebral infarction were present in 11 (73%) of 15 NTG and 6 (50%) of 12 TG mice. The mean area of infarction in the TG group was only 55% that of the NTG group; however, because of data scatter the differences were not statistically significant (Table) .
Assessment of CA1 hippocampal neuronal density indicated severely decreased counts (less than 50% of control) in 11 (73%) of 15 NTG and in 3 (25%) of mice. All NTG animals that showed cerebral infarction also showed severe CA1 damage, whereas only 3 of the 6 infarcted TG animals showed CA1 damage. The overall CA1 counts reflected the above differences, and as a group the TG animals had a statistically significant larger number of surviving CA1 neurons (Table ; Fig 3) . Analysis was also carried out on CA1 neuronal density in male and female subgroups within each experimental exposure, and this indicated no statistical intragroup differences based on sex (ischemic NTG males, 139+54; NTG females, 161+49; ischemic TG males, 252+54; TG females, 270±I28 cells per millimeter CA1 [mean + SEM]; P-NS).
Discussion
Models of experimental hypoxia-ischemia in the mouse have not been as well characterized or widely used as those developed in the rat14,15 and gerbil.16 The present carbon monoxide-carotid artery occlusion-hyperglycemia model was patterned after the hypoxemiaischemia model of Salford et all5 and by the observation that addition of hyperglycemia leads to a high incidence of damage in this model.'7 Because of the limited supply of TG mice it was decided to use this high-incidenceof-injury model with full awareness that the severity of the insult could possibly obscure small but potentially significant trends for enhanced resistance in the test group. In addition, it must be indicated that the model involves a number of potentially independent damaging factors, such as the direct toxic effect of carbon monoxide, ischemia, and tissue acidosis. which could complicate interpretation of the results.
With regard to the above limitations, the results of the present study indicate that the CA1 hippocampus of the bFGF TG mouse shows increased resistance to damage caused by a complex hypoxemic-ischemic insult. This conclusion is supported by data The final possibility to consider is that the process of hypoxic-ischemia cerebral damage is only delayed in the bFGF TG mouse and that with longer survival times the end results in NTG and TG animals would be equivalent. The 5-day recovery period used in the present study may thus be within this "delay" period. Future studies will address this possibility.
In summary, the results indicate that TG mice that overexpress bFGF in the brain have an enhanced ability to resist the effects of a complex hypoxic-ischemic insult, as judged by hippocampal CA1 neuronal survival. These results are complementary to previous studies that have indicated that intraventricular infusions of FGF are neuroprotective in cerebral ischemia. The availability of this strain of TG mouse will allow for future studies aimed at defining the mechanisms responsible for this neuroprotective action.
